Deals
Deals dated after 30 September 2026 are still being collected.
Columns
8 of 8 deals
| Advisers | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 2026 | First Breach | – | – | Direct listing | Legal adviser to the issuer | Announced | – | Cybersecurity | RBW Capital Partners (issuer) | First Breach direct listing |
| Aug 2026 | ARC Group Securities Acquisition I | – | – | IPO | Legal adviser to the issuer | Listed | 105.0 | Investment Vehicles | ARC Group Securities (lead manager)Clear Street (lead manager)Mourant (issuer)Hunter Taubman Fischer & Li (lead manager) | ARC Group Securities Acquisition I IPO |
| Jun 2026 | Mobilewalla | – | SPACSphere Acquisition Corp. | Acquisition | Legal adviser to Mobilewalla (target) | Pending | – | AI+1 | D. Boral Capital (buy-side)Norton Rose Fulbright (buy-side)The Blueshirt Group (sell-side) | SPACSphere Acquisition Corp. acquisition of Mobilewalla |
| May 2026 | VIDA Global | – | – | IPO | Legal adviser to the lead managers | Announced | 15.0 | – | The Benchmark Company (lead manager)Lowenstein Sandler (issuer) | VIDA Global IPO |
| Feb 2026 | Rank One Computing | – | – | IPO | Legal adviser to the issuer | Announced | 24.0 | AI+2 | The Benchmark Company (lead manager)Sheppard, Mullin, Richter & Hampton (lead manager) | Rank One Computing IPO |
| Feb 2026 | Liminatus Pharma | – | – | Follow-on offering | Legal adviser to the lead managers | Announced | 4.0 | Biotech+2 | Maxim Group (lead manager)Loeb & Loeb (issuer) | Liminatus Pharma equity raising |
| Jan 2026 | Buda Juice | – | – | IPO | Legal adviser to the issuer | Announced | 20.0 | Beverages | MDB Capital (lead manager)Golenbock Eiseman Assor Bell & Peskoe (lead manager) | Buda Juice IPO |
| – | Ticketplus | – | – | IPO | Legal adviser to the lead managers | Announced | 15.0 | Media & Entertainment+1 | Bancroft Capital (lead manager)Roth Capital Partners (lead manager)MDB Capital (lead manager)Bevilacqua PLLC (issuer)Mourant (issuer) | Ticketplus IPO |
Activity
By announcement date; raisings and IPOs by their own date.
Sector of the business bought or funded.
Disclosed value in US dollars.
Most often across the table
Firms advising the other side of the same deals.
